Healthcare, biotechnology & medical AI Product
Brainomix 360 has separate clearances for CT angiography and hyperdensity analysis
The Brainomix 360 e-CTA filing covers viewing and analysis of CT angiography. Brainomix 360 Hyperdensity has a separate filing for labeling and measuring areas of increased density on noncontrast head CT. [1][2]
What it does
The FDA cleared Brainomix 360 e-CTA on May 28, 2020, under K192692. It cleared Brainomix 360 Hyperdensity on June 12, 2026, under K260406. [1][2]
Why it matters
The distinction matters because the modules address different image types and deliver different types of information under the same product family. [1][2]
Who it’s for
The named tools support trained professionals who review the specified CT datasets. [1][2]
Key dates
Where it fits
The e-CTA filing describes image review and analysis. Hyperdensity adds specific labels and volume measurements for its own input images. [1][2]
Limits and trade-offs
The two submissions describe named tools with separate indications. They do not cover every application in the Brainomix 360 family. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for Brainomix 360 Hyperdensity (K260406)
- Primary source FDA 510(k) decision for Brainomix 360 e-CTA (K192692)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.